Visitor and Staff Safety Policy and Procedure
BBME shall maintain social distancing and safety measures to help prevent the spread of disease wherever possible.
To give clear guidance regarding additional safety measures being utilized during Covid-19 pandemic.
Staff specific responsibilities and procedures:
1. Clients will be contacted the day before to verify that they have not been directly exposed to Covid-19 or had symptoms such as cough, runny nose, or fever in the last two weeks. Clients will be rescheduled with no penalty if any of these are confirmed.
2. Patients will be asked to bring a mask to their appointment for staff and public safety.
3. Clients may not bring any guests or children to their appointment.
4. Hand sanitizer will be given to all clients and staff upon entering the premises and between all clients.
5. All clients and staff will have their temperature at arrival. Anything 100 degrees and above will prevent treatment, or staff from working. Must be 100-degree fever free for 72 hours.
6. All staff will wear masks and eyewear while actively treating patients.
7. All pens etc will be put away. Each staff will have their personal pen lanyard. Clients will be given their pen to keep if one was used.
8. Clients will pay and exit through the training room to limit people at the front desk
9. Clients will use induvial styluses to sign-out on the ipad. Used stylus’ will be placed in a separate container for sanitization. Alcohol wipes will be used to clean the ipad if touched.
10. Staff will saniwipe touched surfaces, including but not limited door handles, counters, sink handles, chairs, keyboards, clipboards, etc.
11. An additional 10 minutes will be given between every appointment to allow for the treatment rooms to be sanitized.
12. All staff having physical contact with a clients shall wear clean gloves.
13. No more than 2 patients seated at minimum of 6 feet apart shall be in the waiting area.
14. No more than 2 staff members at front desk at any given time.
BBME will not treat:
- Temperature over 100
- Respiratory symptoms such as cough, runny nose, sneezing.
- Less than 2 weeks Covid-19 exposure
- Pregnant and nursing
Recommend not treating at this time:
- People with chronic lung disease or moderate to severe asthma
- People who have serious heart conditions
- People who are immunocompromised
- Many conditions can cause a person to be immunocompromised, including cancer treatment, bone marrow or organ transplantation, immune deficiencies, poorly controlled HIV or AIDS, and prolonged use of corticosteroids and other immune weakening medications
- People with poorly controlled diabetes
- People with chronic kidney disease undergoing dialysis
- People with liver disease
Patients taking Immunosuppressant Drugs:
- abatacept (Orencia)
- adalimumab (Humira)
- anakinra (Kineret)
- certolizumab (Cimzia)
- etanercept (Enbrel)
- golimumab (Simponi)
- infliximab (Remicade)
- ixekizumab (Taltz)
- natalizumab (Tysabri)
- rituximab (Rituxan)
- secukinumab (Cosentyx)
- tocilizumab (Actemra)
- ustekinumab (Stelara)
- vedolizumab (Entyvio)
- IMDH inhibitors
- azathioprine (Azasan, Imuran)
- leflunomide (Arava)
- mycophenolate (CellCept, Myfortic)
- mTOR inhibitors
- sirolimus (Rapamune)
- everolimus (Afinitor, Zortress)
- Calcineurin inhibitors
- cyclosporine (Neoral, Sandimmune, SangCya)
- tacrolimus (Astagraf XL, Envarsus XR, Prograf)
Janus kinase inhibitors
- tofacitinib (Xeljanz)
- prednisone (Deltasone, Orasone)
- budesonide (Entocort EC)
- prednisolone (Millipred)